The 15th annual SCOPE Summit 2024 was a huge success with participation of over 3000+ attendees from 800+ companies! One of the overarching themes at the summit was the growing importance of patient-centric approaches in clinical research. TrialX’s participation was marked by the unveiling of our latest innovation – an AI-powered solution designed to simplify clinical trial information for patients. Read More.
What’s new at TrialX?
PRODUCT UPDATES
The third in a series of proposed Axiom Space human spaceflight missions, the Ax-3 mission splashed down safely this month. The crew conducted more than 30 different experiments for 18 days aboard the orbiting laboratory on the ISS. The Translational Research Institute for Space Health (TRISH) team collected biomedical data with the spaceflight participants at Kennedy Space Center after splashdown. In partnership with TRISH, we are thrilled to support pre-flight, in-flight and post-flight health research data collection and storage from commercial astronauts during these space missions. Click here to learn about some of the research projects that are a part of this mission.
Antibiotic resistance is a pressing global health issue, exacerbated by the rampant overuse and misuse of antibiotics. Using TrialX’s remote data collection solutions, researchers at the University of Iowa, developed a SAYSTOP study app to investigate if it is safe for patients to stop their antibiotics when they feel better compared to completing all of their antibiotic pills for urinary tract infections (UTI). This user-friendly mobile application will enable study participants to track and manage their antibiotic usage with ease.
RECENT CURETALKS 
Lecithin cholesterol acyltransferase (LCAT) deficiency is a genetic disorder that affects the body’s ability to process cholesterol. Fewer than 1000 people in the US have this disease which is characterized by corneal opacity, hemolytic anemia and kidney failure. In our recent CureTalks episode watch patient advocates Jason and Beverley talk to Dr. Marina Cuchel from University of Pennsylvania to understand the condition better. Watch here.
FEATURED CLINICAL STUDIES
Powered by TrialX
Nutrition Research Food, Genetics, Behavior Study (FOODIE): This study aims to identify the interplay between behaviors and genes on growth and development among children ages 5 to 7. It assesses the extent to which children’s eating, sleep, and physical activity behaviors impacts their weight development over a 1-year period. Learn more.
VOLUNTEERS AGES 50-64 NEEDED FOR STRESS STUDY! Researchers in the IU School of Public Health are looking for volunteers to take part in a study to better understand the stressors experienced by people as they go about their everyday lives. Learn more.
Responsive Neurostimulation for Loss of Control Over Eating: This is an early feasibility study looking at the safety, feasibility, and potential benefit of a medical device, called the NeuroPace RNS System, for people suffering from obesity, with uncontrolled eating habits. Learn more.
AROUND THE WEB
An antiviral drug grown in orbit.
Another arrow in the quiver against antibiotic resistance.
️ What would happen to a dead body in space?
Neuralink’s first patient can move a mouse with their thoughts.
The FDA Speaks Up For Quality Management: Must They Beg?
Track and explore all rocket launches!
At TrialX, we strive to revolutionize the way clinical trials are conducted on earth and in space, by focusing on innovative solutions streamlining patient recruitment and remote data collection. Stay tuned for more updates as we continue to look up to the moon!
All the best,
Team TrialX
